ANTX Live signals | Maximize Profits with Getagraph.com

SELL 110892 min ago

@ $20.32

Issued: 8 Feb 2024 @ 09:30

Return: -88.43%

Previous signal: Feb 6 - 12:43

Previous signal: Buy

Return: 0.27 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 10:30):

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases...

Stats
Today's Volume	20 296.00
Average Volume	479 051
Market Cap	69.97M
EPS	$-0.650 ( 2023-11-09 )
Next earnings date	( $-0.610 ) 2024-05-09
Last Dividend	$0.656 ( 2018-01-11 )
Next Dividend	$0 ( N/A )
P/E	-0.860
ATR14	$0.0160 (0.68%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Eckburg Paul	Buy	30 000	Common Stock
2024-03-15	Day Lucy	Buy	55 000	Stock Option (right to buy)
2024-03-15	Day Lucy	Buy	27 500	Common Stock
2024-03-15	Eizen Joshua M	Buy	60 000	Stock Option (right to buy)
2024-03-15	Eizen Joshua M	Buy	30 000	Common Stock

INSIDER POWER
65.47
Last 100 transactions
Buy: 3 449 514 \| Sell: 642 134

Volume Correlation

Long: -0.11 (neutral)

Short: -0.14 (neutral)

Signal:(45.146) Neutral

Anthem Inc. Corporate Correlation

10 Most Positive Correlations
SFL	0.949
MIC	0.937
X	0.923
APO-PA	0.921
FLSP	0.92
UBS	0.912
CEIX	0.907
PSN	0.903
CXW	0.901
HRB	0.898

10 Most Negative Correlations
HE	-0.92
ENIA	-0.915
AGTI	-0.909
RMD	-0.906
SFUN	-0.903
FNA	-0.899
NWE	-0.899
K	-0.898
HIPO	-0.89
NUV	-0.888

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anthem Inc. Corporate Correlation - Currency/Commodity

0.33
( neutral )

0.41
( neutral )

0.00
( neutral )

-0.34
( neutral )

0.00
( neutral )

-0.61
( weak negative )

Anthem Inc. Corporate Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-2.74

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.570

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.650

Q2	2023
Revenue:	$0
Gross Profit:	$-21 000.00 (0.00 %)
EPS:	$-0.810

Financial Reports:

No articles found.

Anthem Inc. Corporate Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Anthem Inc. Corporate Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.576	2015-07-13
Last Dividend	$0.656	2018-01-11
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$7.14	--
Avg. Dividend % Per Year	0.00%	--
Score	1.61	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

1.61

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0.656	1.15%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.461	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.590	1.500	-7.67	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.87	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.74	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.114	1.500	4.92	7.38	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	97.26	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.195	[0 - 30]
freeCashFlowPerShareTTM	-1.792	2.00	-0.896	-1.792	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.272

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.115	1.000	-0.214	0	[1 - 100]
returnOnEquityTTM	-0.590	2.50	-4.93	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.792	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.195	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.510

Anthem Inc. Corporate

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.